Your Health, We Care
The following clinically significant adverse reactions are described elsewhere in the labeling:
1. Gastrointestinal Adverse Reactions
2. QTc Interval Prolongation
3. Hepatotoxicity
4. Interstitial Lung Disease (ILD)/Pneumonitis
FDA,2022.12
